Who will be the first sponsor to take an application to a “virtual” advisory committee hosted by the US Food & Drug Administration?
While one can always hope that the COVID-19 outbreak recedes quickly enough that FDA will feel comfortable convening in person meetings again in the near future, it is far more likely that the next time a new drug application goes
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?